| |
| |
|
| Insider
Information: |
Williams Timothy |
| Relationship: |
|
| City: |
Washington |
| State: |
DC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
196,825 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$909,332 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
196,825 |
|
|
| Total
Value |
$909,332 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
15
|
|
Stock
price went up :
|
0
|
5
|
| Stock
price went down : |
0
|
10
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -161.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vanda Pharmaceuticals Inc. |
VNDA |
|
2024-03-05 |
196,825 |
2018-08-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
23 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP & General Counsel |
• – – |
2024-03-05 |
4 |
S |
$4.18 |
$37,396 |
D/D |
(8,941) |
196,825 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP & General Counsel |
• – – |
2024-03-04 |
4 |
S |
$4.41 |
$35,917 |
D/D |
(8,147) |
205,766 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP & General Counsel |
• – – |
2024-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
125,000 |
213,913 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP & General Counsel |
• – – |
2023-06-13 |
4 |
S |
$6.56 |
$95,754 |
D/D |
(14,600) |
88,913 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP & General Counsel |
• – – |
2023-03-03 |
4 |
S |
$6.25 |
$51,887 |
D/D |
(8,301) |
103,513 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP & General Counsel |
• – – |
2023-03-02 |
4 |
S |
$6.24 |
$52,685 |
D/D |
(8,437) |
111,814 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP & General Counsel |
• – – |
2023-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
32,700 |
120,251 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP & General Counsel |
• – – |
2022-12-15 |
4 |
S |
$7.01 |
$56,070 |
D/D |
(8,000) |
87,551 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP & General Counsel |
• – – |
2022-08-15 |
4 |
S |
$10.21 |
$85,504 |
D/D |
(8,300) |
95,551 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP & General Counsel |
• – – |
2022-03-02 |
4 |
S |
$11.09 |
$133,779 |
D/D |
(12,060) |
103,851 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP & General Counsel |
• – – |
2022-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
32,700 |
115,911 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP & General Counsel |
• – – |
2021-08-16 |
4 |
S |
$16.15 |
$59,989 |
D/D |
(3,715) |
83,211 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP & General Counsel |
• – – |
2021-03-05 |
4 |
S |
$17.85 |
$99,966 |
D/D |
(5,600) |
86,926 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP & General Counsel |
• – – |
2021-03-02 |
4 |
S |
$18.54 |
$142,307 |
D/D |
(7,674) |
92,526 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP & General Counsel |
• – – |
2021-03-01 |
4 |
S |
$18.60 |
$220,543 |
D/D |
(11,856) |
100,200 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP & General Counsel |
• – – |
2021-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
32,700 |
112,056 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP & General Counsel |
• – – |
2020-08-14 |
4 |
S |
$11.81 |
$43,526 |
D/D |
(3,684) |
79,356 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP & General Counsel |
• – – |
2020-03-03 |
4 |
S |
$10.51 |
$13,004 |
D/D |
(1,237) |
83,040 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP & General Counsel |
• – – |
2020-03-02 |
4 |
S |
$10.30 |
$32,436 |
D/D |
(3,148) |
84,277 |
0 |
% |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP & General Counsel |
• – – |
2020-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
87,425 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP & General Counsel |
• – – |
2019-08-14 |
4 |
S |
$14.69 |
$37,829 |
D/D |
(2,575) |
57,425 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP & General Counsel |
• – – |
2019-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
60,000 |
0 |
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
SVP & General Counsel |
• – – |
2018-08-13 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
30,000 |
0 |
- |
|
23 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
